PHOENIX, May 16, 2024
/PRNewswire/ -- Trinity Capital Inc. (NASDAQ: TRIN)
("Trinity"), a leading provider of diversified financial solutions
to growth-stage companies, today announced the commitment of
$60 million in growth capital to
Metabolon, a global leader in providing metabolomics solutions
advancing a wide variety of life science research, diagnostic,
therapeutic development, and precision medicine applications.
Metabolon develops scientific, technological, and bioinformatics
techniques to measure inputs from internal and external factors
such as health, disease, nutrition, microbiome, medication, and
environmental exposure, to help answer scientific questions about
health and disease. Metabolon's customizable metabolomics solutions
support research in the biopharma, population
health, consumer products, agriculture, wellness, academic,
and government sectors, across the research continuum.
"We are excited to partner with Metabolon, a company that has
demonstrated innovation and excellence in the life sciences
sector," said Rob Lake, Senior
Managing Director, Life Sciences at Trinity. "By leveraging their
cutting-edge technology and extensive experience, the team has the
potential to accelerate research and we look forward to supporting
the company's ongoing growth and expansion in the industry."
This new growth capital will allow Metabolon to expand its
research and development efforts to further enhance its
metabolomics platform. The investment will also support the
company's global expansion plans, including market penetration
initiatives and strategic partnerships.
"We are extremely pleased to announce this successful financing
with Trinity, marking a significant milestone for Metabolon. This
infusion of additional capital and robust process leading up to it
underscore the strong investor confidence in Metabolon's vision,
capabilities, and market potential within the multiomics and
metabolomics industry" said Rohan (Ro)
Hastie Chief Executive Officer at Metabolon. "As the life
sciences embrace a sophisticated multiomics paradigm, Metabolon is
emerging as an industry benchmark and an essential catalyst toward
achieving true precision medicine. This investment will enable us
to accelerate growth, drive innovation, and further solidify our
position as a leader in the metabolomics space."
About Trinity Capital Inc.
Trinity (Nasdaq: TRIN), an
internally managed business development company, is a leading
provider of diversified financial solutions to growth stage
companies with institutional equity investors. Trinity's investment
objective is to generate current income and, to a lesser extent,
capital appreciation through investments, including term loans,
equipment financings and equity-related investments. Trinity
believes it is one of only a select group of specialty lenders that
has the depth of knowledge, experience, and track record in lending
to growth stage companies. For more information, please visit the
Company's website at www.trinitycap.com.
About Metabolon
Metabolon, Inc. is the global leader
in metabolomics, with a mission to deliver biochemical data and
insights that expand and accelerate the impact of life sciences
research and complement other 'omics' technologies. With more than
20 years, 10,000+ projects, 3,000+ publications, and ISO 9001:2015,
CLIA, and CAP certifications, Metabolon has developed
industry-leading scientific, technology, and bioinformatics
techniques. Metabolon's Global Discovery Panel is enabled by the
world's largest proprietary metabolomics reference library.
Metabolon's industry-leading data and translational science
expertise help customers and partners address some of the most
challenging and pressing questions in the life sciences,
accelerating research and enhancing development success. The
company offers scalable, customizable multiomics solutions,
including metabolomics and lipidomics, supporting customer needs
from discovery through clinical trials and product life-cycle
management. For more information, please
visit www.metabolon.com and follow us
on LinkedIn and Twitter.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/trinity-capital-inc-provides-60-million-in-growth-capital-to-metabolon-302146651.html
SOURCE Trinity Capital Inc.